Telemedicine and Prescription Regulations: What Providers and Patients Should Know

Telemedicine has dramatically expanded access to healthcare services, making it easier for patients to receive care without visiting a clinic or hospital. However, this convenience also brings complexity—especially when it comes to prescribing medications. As virtual care becomes more widespread, both providers and patients must understand the evolving landscape of prescription regulations in telemedicine.

The Rise of Teleprescribing

The COVID-19 pandemic accelerated the adoption of telemedicine and, with it, teleprescribing—the ability to prescribe medications during a virtual visit. Emergency waivers allowed providers to prescribe a broad range of medications without an initial in-person visit, a shift that helped maintain care continuity during lockdowns.

Today, many of those temporary regulations are being reevaluated or replaced with permanent laws. As a result, teleprescribing is here to stay, but it comes with stricter oversight and varying rules depending on the state, the type of medication, and the provider’s licensure.

Controlled Substances: A Special Category

Controlled substances—including opioids, ADHD medications, and some anti-anxiety drugs—are subject to the most stringent regulations. In the U.S., the Drug Enforcement Administration (DEA) requires that these drugs be prescribed only after an in-person evaluation, although recent updates have allowed some exceptions through telemedicine.

Under the Ryan Haight Online Pharmacy Consumer Protection Act, providers generally cannot prescribe controlled substances via telemedicine without first seeing the patient in person. However, proposed updates to this rule would allow certain telehealth providers to prescribe controlled medications under specific circumstances, such as when a provider is part of a DEA-registered telehealth practice.

Providers should stay informed about DEA policy changes and state-level regulations to ensure compliance and avoid legal issues. Patients, meanwhile, should understand that not all medications are immediately available via telemedicine and may require an in-person appointment.

State Licensing and Interstate Practice

Another important consideration is state licensure. In most cases, a provider must be licensed in the state where the patient is physically located during the telemedicine visit. This has major implications for teleprescribing, especially for providers offering care across state lines.

Some states participate in licensure compacts, such as the Interstate Medical Licensure Compact (IMLC), which streamline the process for physicians to practice in multiple states. However, not all healthcare professionals or states are part of these agreements.

For patients receiving care from out-of-state providers, it’s essential to verify whether prescriptions will be valid in their location. Providers must also ensure that they are authorized to prescribe medications in the states where their patients reside.

Electronic Prescribing (ePrescribing) Systems

ePrescribing platforms play a key role in telemedicine prescription workflows. These secure, electronic systems allow providers to send prescriptions directly to pharmacies, reducing errors, increasing efficiency, and improving medication tracking.

In many regions, ePrescribing is now required for controlled substances, adding another layer of compliance. Providers must use DEA-certified software, complete identity verification, and follow two-factor authentication protocols.

Patients benefit from the convenience of ePrescribing, but they should also be aware that some pharmacies may not accept certain types of telemedicine prescriptions or may have policies requiring verification for controlled medications.

Ethical and Safety Considerations

Prescribing medication through telemedicine presents unique clinical and ethical challenges. Without an in-person physical exam, providers must rely heavily on patient-reported symptoms and medical history. This makes accurate documentation and thorough patient interviews essential.

Providers must also consider the risk of overprescribing, drug interactions, and misuse, particularly with medications that carry dependency risks. Telemedicine platforms can support safe prescribing practices by incorporating decision-support tools, medication histories, and alerts for potential contraindications.

Patient education is equally important. Providers should clearly explain dosage, side effects, and the importance of adherence during virtual visits, and ensure patients understand when to seek follow-up care.

Preparing for Future Regulatory Changes

As telemedicine becomes a permanent fixture in healthcare, so too will regulatory updates. Providers should expect ongoing changes in DEA rules, state laws, and insurance reimbursement policies related to teleprescribing.

Staying informed, maintaining detailed documentation, and using secure, compliant platforms are key to navigating this evolving environment. Patients should also be proactive in understanding their options, rights, and responsibilities when receiving prescriptions via telemedicine.

Conclusion

Telemedicine has opened the door to more convenient and accessible prescription services, but navigating the regulatory landscape requires attention and care. Both providers and patients must stay informed about the legal and ethical considerations surrounding teleprescribing—especially when it comes to controlled substances and interstate care. 

At CareExpand, we help healthcare organizations deliver secure, compliant, and patient-focused virtual care, empowering providers to prescribe responsibly and patients to access the medications they need safely and efficiently.

‍